Skip to main content
Top
Published in: BMC Immunology 1/2021

Open Access 01-12-2021 | Research

Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China

Authors: Bin Wei, Ying Guo, Liangjun Zhang, Huixiu Zhong, Qiang Miao, Lin Yan, Yangjuan Bai, Weihua Feng, Weiping Liu, Qian Niu, Yi Li

Published in: BMC Immunology | Issue 1/2021

Login to get access

Abstract

Background

Appropriate reference ranges of T lymphocyte subsets are essential for immune status evaluation of patients with immunological diseases. We aim to establish the age- and sex-related reference intervals of T lymphocyte subsets by single-platform for the southwest China population using the indirect method with the data resulting from 53,822 cases of periodic health examination individuals in the Laboratory Information System (LIS) of West China Hospital from 2018 to 2020.

Methods

We used the Box-Cox conversion combined with the Tukey method to normalize the data and eliminate the outliers, and the nonparametric method to estimate the 95% distribution reference intervals.

Results

We initially established the reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China by indirect method (See text for details). Using the standard normal deviate test (z-test) suggested by Harris and Boyd according to CLSI EP28-A3C, which is more scientific, we found the reference ranges of T lymphocyte subsets should be differentiated by ages and genders since the reference ranges of T lymphocyte subsets by single-platform in different ages and genders are significantly different.

Conclusions

We further demonstrated the absolute count of CD3 + T cell, CD3 + CD4 + T cell, CD3 + CD8 + T cell decreased with aging, which is more marked in men and CD3 + CD8 + T cell count, and the obtained reference intervals were superior to the reference intervals derived from the reagent specification currently in use.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kumar BV, Connors TJ, Farber DL. Human T cell development, localization, and function throughout life. Immunity. 2018;48(2):202–13.CrossRef Kumar BV, Connors TJ, Farber DL. Human T cell development, localization, and function throughout life. Immunity. 2018;48(2):202–13.CrossRef
2.
go back to reference Gaud G, Lesourne R, Love PE. Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol. 2018;18(8):485–97.CrossRef Gaud G, Lesourne R, Love PE. Regulatory mechanisms in T cell receptor signalling. Nat Rev Immunol. 2018;18(8):485–97.CrossRef
3.
go back to reference Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018;33(4):547–62.CrossRef Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. 2018;33(4):547–62.CrossRef
4.
go back to reference Gu Y, Jin Y, Ding J, et al. Low absolute CD4(+) T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma. Leuk Lymphoma. 2020;61(8):1869–76.CrossRef Gu Y, Jin Y, Ding J, et al. Low absolute CD4(+) T cell counts in peripheral blood predict poor prognosis in patients with newly diagnosed multiple myeloma. Leuk Lymphoma. 2020;61(8):1869–76.CrossRef
5.
go back to reference Manasanch EE, Gertz MA. Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield. Leuk Lymphoma. 2020;61(8):1777–9.CrossRef Manasanch EE, Gertz MA. Exhausted and outnumbered: CD4+ T cells in the myeloma battlefield. Leuk Lymphoma. 2020;61(8):1777–9.CrossRef
6.
go back to reference Cao X, Kong YL, Wang L, et al. Circulating low CD4(+)/CD8(+) ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients. Ann Hematol. 2021;100(4):995–1002.CrossRef Cao X, Kong YL, Wang L, et al. Circulating low CD4(+)/CD8(+) ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients. Ann Hematol. 2021;100(4):995–1002.CrossRef
7.
go back to reference Zhang XY, Xu J, Zhu HY, et al. Negative prognostic impact of low absolute CD4(+) T cell counts in peripheral blood in mantle cell lymphoma. Cancer Sci. 2016;107(10):1471–6.CrossRef Zhang XY, Xu J, Zhu HY, et al. Negative prognostic impact of low absolute CD4(+) T cell counts in peripheral blood in mantle cell lymphoma. Cancer Sci. 2016;107(10):1471–6.CrossRef
8.
go back to reference Arneth B. Activated CD4+ and CD8+ T cell proportions in multiple sclerosis patients. Inflammation. 2016;39(6):2040–4.CrossRef Arneth B. Activated CD4+ and CD8+ T cell proportions in multiple sclerosis patients. Inflammation. 2016;39(6):2040–4.CrossRef
9.
go back to reference McBride JA, Striker R. Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog 2017; 13(11): e1006624. McBride JA, Striker R. Imbalance in the game of T cells: What can the CD4/CD8 T-cell ratio tell us about HIV and health? PLoS Pathog 2017; 13(11): e1006624.
10.
go back to reference Wu TD, Madireddi S, de Almeida PE, et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020;579(7798):274–8.CrossRef Wu TD, Madireddi S, de Almeida PE, et al. Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature. 2020;579(7798):274–8.CrossRef
11.
go back to reference Helleberg M, Kronborg G, Ullum H, et al. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals. J Infect Dis. 2015;211(11):1726–34.CrossRef Helleberg M, Kronborg G, Ullum H, et al. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals. J Infect Dis. 2015;211(11):1726–34.CrossRef
12.
go back to reference Wing JB, Tanaka A, Sakaguchi S. Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50(2):302–16.CrossRef Wing JB, Tanaka A, Sakaguchi S. Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer. Immunity. 2019;50(2):302–16.CrossRef
13.
go back to reference Glatzova D, Cebecauer M. Dual role of CD4 in peripheral T lymphocytes. Front Immunol. 2019;10:618.CrossRef Glatzova D, Cebecauer M. Dual role of CD4 in peripheral T lymphocytes. Front Immunol. 2019;10:618.CrossRef
14.
go back to reference Zander R, Schauder D, Xin G, et al. CD4(+) T cell help Is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer. Immunity. 2019;51(6):1028–42.CrossRef Zander R, Schauder D, Xin G, et al. CD4(+) T cell help Is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer. Immunity. 2019;51(6):1028–42.CrossRef
15.
go back to reference CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition. CLSI document EP28 – A3c ed Wayne, PA, USA: CLSI (Clinical Laboratory Standards Institute). 2010. CLSI. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition. CLSI document EP28 – A3c ed Wayne, PA, USA: CLSI (Clinical Laboratory Standards Institute). 2010.
16.
go back to reference Adoga MP, Pennap GR, John PA, et al. CD4- and CD3-T lymphocyte reference values of immunocompetent urban and rural subjects in an African nation. Scand J Immunol. 2012;76(1):33–8.CrossRef Adoga MP, Pennap GR, John PA, et al. CD4- and CD3-T lymphocyte reference values of immunocompetent urban and rural subjects in an African nation. Scand J Immunol. 2012;76(1):33–8.CrossRef
17.
go back to reference Lerkvaleekul B, Apiwattanakul N, Klinmalai C, et al. Age-related changes in lymphocyte subpopulations in healthy Thai children. J Clin Lab Anal. 2020;34(5):e23156.CrossRef Lerkvaleekul B, Apiwattanakul N, Klinmalai C, et al. Age-related changes in lymphocyte subpopulations in healthy Thai children. J Clin Lab Anal. 2020;34(5):e23156.CrossRef
18.
go back to reference Mulu W, Abera B, Mekonnen Z, et al. Haematological and CD4+ T cells reference ranges in healthy adult populations in Gojjam zones in Amhara region, Ethiopia. PLoS One. 2017;12(7):e0181268.CrossRef Mulu W, Abera B, Mekonnen Z, et al. Haematological and CD4+ T cells reference ranges in healthy adult populations in Gojjam zones in Amhara region, Ethiopia. PLoS One. 2017;12(7):e0181268.CrossRef
19.
go back to reference Qin L, Jing X, Qiu ZF, et al. Aging of immune system: Immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults. Aging. 2016;8(5):848–59.CrossRef Qin L, Jing X, Qiu ZF, et al. Aging of immune system: Immune signature from peripheral blood lymphocyte subsets in 1068 healthy adults. Aging. 2016;8(5):848–59.CrossRef
20.
go back to reference Tang GX, Yuan X, Luo Y, et al. Establishing immune scoring model based on combination of the number, function, and phenotype of lymphocytes. Aging. 2020;12(10):9328–43.CrossRef Tang GX, Yuan X, Luo Y, et al. Establishing immune scoring model based on combination of the number, function, and phenotype of lymphocytes. Aging. 2020;12(10):9328–43.CrossRef
21.
go back to reference Niu HQ, Zhao XC, Li W, et al. Characteristics and reference ranges of CD4(+)T cell subpopulations among healthy adult Han Chinese in Shanxi Province, North China. BMC Immunol. 2020;21(1):44.CrossRef Niu HQ, Zhao XC, Li W, et al. Characteristics and reference ranges of CD4(+)T cell subpopulations among healthy adult Han Chinese in Shanxi Province, North China. BMC Immunol. 2020;21(1):44.CrossRef
22.
go back to reference Jia L, Li J, Zhang Y, et al. Age- and sex-related reference intervals of lymphocyte subsets in healthy ethnic Han Chinese children. Cytometry A. 2015;87(12):1116–26.CrossRef Jia L, Li J, Zhang Y, et al. Age- and sex-related reference intervals of lymphocyte subsets in healthy ethnic Han Chinese children. Cytometry A. 2015;87(12):1116–26.CrossRef
23.
go back to reference Zhang X, Ding Y, Zhang Y, et al. Age- and sex-specific reference intervals for hematologic analytes in Chinese children. Int J Lab Hematol. 2019;41(3):331–7.CrossRef Zhang X, Ding Y, Zhang Y, et al. Age- and sex-specific reference intervals for hematologic analytes in Chinese children. Int J Lab Hematol. 2019;41(3):331–7.CrossRef
24.
go back to reference Lo Sasso B, Vidali M, Scazzone C, et al. Reference interval by the indirect approach of serum thyrotropin (TSH) in a Mediterranean adult population and the association with age and gender. Clin Chem Lab Med. 2019;57(10):1587–94.CrossRef Lo Sasso B, Vidali M, Scazzone C, et al. Reference interval by the indirect approach of serum thyrotropin (TSH) in a Mediterranean adult population and the association with age and gender. Clin Chem Lab Med. 2019;57(10):1587–94.CrossRef
25.
go back to reference Zierk J, Arzideh F, Haeckel R, et al. Pediatric reference intervals for alkaline phosphatase. Clin Chem Lab Med. 2017;55(1):102–10.CrossRef Zierk J, Arzideh F, Haeckel R, et al. Pediatric reference intervals for alkaline phosphatase. Clin Chem Lab Med. 2017;55(1):102–10.CrossRef
26.
go back to reference Valiathan R, Deeb K, Diamante M, et al. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Immunobiology. 2014;219:487–96.CrossRef Valiathan R, Deeb K, Diamante M, et al. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida. Immunobiology. 2014;219:487–96.CrossRef
27.
go back to reference Al-Thani A, Hamdi WS, Al-Marwani A, et al. Reference ranges of lymphocyte subsets in healthy Qatari adults. Biomark Med. 2015;9(5):443–52.CrossRef Al-Thani A, Hamdi WS, Al-Marwani A, et al. Reference ranges of lymphocyte subsets in healthy Qatari adults. Biomark Med. 2015;9(5):443–52.CrossRef
28.
go back to reference Al-Mawali A, Pinto AD, Al Busaidi R, et al. Lymphocyte subsets: reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry A. 2013;83(8):739–44.CrossRef Al-Mawali A, Pinto AD, Al Busaidi R, et al. Lymphocyte subsets: reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry A. 2013;83(8):739–44.CrossRef
29.
go back to reference Jentsch-Ullrich K, Koenigsmann M, Mohren M, et al. Lymphocyte subsets’ reference ranges in an age- and gender-balanced population of 100 healthy adults–a monocentric German study. Clin Immunol. 2005;116(2):192–7.CrossRef Jentsch-Ullrich K, Koenigsmann M, Mohren M, et al. Lymphocyte subsets’ reference ranges in an age- and gender-balanced population of 100 healthy adults–a monocentric German study. Clin Immunol. 2005;116(2):192–7.CrossRef
30.
go back to reference Brown MA, Su MA. An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses. J Immunol. 2019;202(7):1927–33.CrossRef Brown MA, Su MA. An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses. J Immunol. 2019;202(7):1927–33.CrossRef
31.
go back to reference Aldridge J, Pandya JM, Meurs L, et al. Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients. Arthritis Res Ther. 2018;20(1):150.CrossRef Aldridge J, Pandya JM, Meurs L, et al. Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients. Arthritis Res Ther. 2018;20(1):150.CrossRef
32.
go back to reference Pangrazzi L, Weinberger B. T cells, aging and senescence. Exp Gerontol 2020; 134: 110887. Pangrazzi L, Weinberger B. T cells, aging and senescence. Exp Gerontol 2020; 134: 110887.
33.
go back to reference Li M, Yao D, Zeng X, et al. Age related human T cell subset evolution and senescence. Immun Ageing. 2019;16:24.CrossRef Li M, Yao D, Zeng X, et al. Age related human T cell subset evolution and senescence. Immun Ageing. 2019;16:24.CrossRef
34.
go back to reference Minato N, Hattori M, Hamazaki Y. Physiology and pathology of T-cell aging. Int Immunol. 2020;32(4):223–31.CrossRef Minato N, Hattori M, Hamazaki Y. Physiology and pathology of T-cell aging. Int Immunol. 2020;32(4):223–31.CrossRef
35.
go back to reference Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression-implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16:356–71.CrossRef Togashi Y, Shitara K, Nishikawa H. Regulatory T cells in cancer immunosuppression-implications for anticancer therapy. Nat Rev Clin Oncol. 2019;16:356–71.CrossRef
36.
go back to reference Botafogo V, Perez-Andres M, Jara-Acevedo M, et al. Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-Color euroflow immune monitoring tube. Front Immunol. 2020;11:166.CrossRef Botafogo V, Perez-Andres M, Jara-Acevedo M, et al. Age distribution of multiple functionally relevant subsets of CD4+ T cells in human blood using a standardized and validated 14-Color euroflow immune monitoring tube. Front Immunol. 2020;11:166.CrossRef
37.
go back to reference Garcia-Prat M, Alvarez-Sierra D, Aguilo-Cucurull A, et al. Extended immunophenotyping reference values in a healthy pediatric population. Cytometry B Clin Cytom. 2019;96(3):223–33.CrossRef Garcia-Prat M, Alvarez-Sierra D, Aguilo-Cucurull A, et al. Extended immunophenotyping reference values in a healthy pediatric population. Cytometry B Clin Cytom. 2019;96(3):223–33.CrossRef
Metadata
Title
Reference ranges of T lymphocyte subsets by single-platform among healthy population in southwest China
Authors
Bin Wei
Ying Guo
Liangjun Zhang
Huixiu Zhong
Qiang Miao
Lin Yan
Yangjuan Bai
Weihua Feng
Weiping Liu
Qian Niu
Yi Li
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2021
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/s12865-021-00474-0

Other articles of this Issue 1/2021

BMC Immunology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.